FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054392 [Registered on: 26/06/2023] Trial Registered Prospectively
Last Modified On: 23/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Raktamokshana & Marma Chikitsa with Aabhadi churna in Gridhrasi (Sciatica) 
Scientific Title of Study   A comparative clinical study of Raktamokshana & Marma Chikitsa with Aabhadi churna in Gridhrasi(Sciatica) 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vimal Kumar 
Designation  Associate Professor 
Affiliation  Uttarakhand Ayurved University Rishikul Campus Haridwar 
Address  OPD NO.7 Department of Shalya Tantra,Rishikul Ayurved Hospital, Rishikul Campus,Uttarakhand Ayurved University, Haridwar 249401 Uttarakhand India

Hardwar
UTTARANCHAL
249401
India 
Phone  9415812272  
Fax    
Email  imsvimal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vimal Kumar 
Designation  Professor 
Affiliation  Uttarakhand Ayurved University Rishikul Campus Haridwar 
Address  OPD NO.7 Department of Shalya Tantra,Rishikul Ayurved Hospital, Rishikul Campus,Uttarakhand Ayurved University, Haridwar 249401 Uttarakhand India

Hardwar
UTTARANCHAL
249401
India 
Phone  9415812272  
Fax    
Email  imsvimal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Himani 
Designation  PG Scholar  
Affiliation  Uttarakhand Ayurved University Rishikul Campus Haridwar 
Address  OPD NO.7 Department of Shalya Tantra,Rishikul Ayurved Hospital, Rishikul Campus,Uttarakhand Ayurved University, Haridwar 249401 Uttarakhand India

Hardwar
UTTARANCHAL
249401
India 
Phone  7895985051  
Fax    
Email  himanirana113@gmail.com  
 
Source of Monetary or Material Support  
Rishikul Campus, Uttarakhand Ayurved University Haridwar 
 
Primary Sponsor  
Name  Uttarakhand Ayurved University 
Address  Uttarakhand Ayurved University, Railway Road, Harrawala Dehradun 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Himani  Uttarakhand Ayurved University Rishikul campus, haridwar  OPD NO.7 Department of Shalya Tantra,Rishikul Ayurved Hospital, Rishikul Campus,Uttarakhand Ayurved University, Haridwar 249401 Uttarakhand India
Hardwar
UTTARANCHAL 
07895985051

himanirana113@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Uttarakhand Ayurved University Rishikul campus   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M00-M99||Diseases of the musculoskeletal system and connective tissue. Ayurveda Condition: Gridhrasi (Sciatica), (2) ICD-10 Condition:M543||Sciatica. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-raktamokShaNam/ SoNitasrAvaH/ asravisrutiH/ SastravisrAvaNam, रक्तमोक्षणम्/ शोणितस्रावः/ अस्रविस्रुतिः/शस्त्रà (Procedure Reference: Sushrut shareer sthana, Procedure details: raktamokshans (15 -20ml) from most tender point)
2Intervention ArmProcedure-marmacikitsA, मर्मचिकित्सा (Procedure Reference: Sushrut Shareer sthana, Procedure details: Press Katiktarun, kukundar, Janu & Gulph marma each one by one for 18 to 20 times.)
(1) Medicine Name: Aabhadi Churna, Reference: Yogratnakar, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Duration: 45 Days
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patient who have classical sign and symptoms of Gridhrasi.
Patients of age group between 16- 70 years.
Willingness of patients for study. 
 
ExclusionCriteria 
Details  Pregnancy
Tuberculosis
Anaemia (Hb<10gm %)
Cardiac diseases
Uncontrolled Hypertension
Diabetes Mellitus
HIV positive
Hepatitis A, B, C positive
Malignancy of spine or other organs
History of spine fracture (trauma)
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Pain (Ruka)
Stambha (Stiffness)
Aruchi (aversion of food)
Spandana (throbbing / pulsating)
Gaurava (heaviness) 
At 1st, 14th, 28th, 42nd days 
 
Secondary Outcome  
Outcome  TimePoints 
Gradation for S.L.R  At 1st, 14th, 28th, 42nd days 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a open label, randomized, parallel group control trial to determine the efficacy of Marma Chikitsa along with Aabhadi Churana in one group and Raktamoksana in another group for age group between 16- 70 years for 45 days. Study will be conduct at UAU, Rishikul Campus, Haridwar on 36 patients. Assessment will be done on the basis of subjective and objective parameters. Study will be conducted at OPD/IPD level of PG department of Shalya Tantra.  Assessment will be done at the interval of 14 days of clinical trial and result obtained will be tabulated and statistically analyzed using appropriate tests.  
Close